Assay ID | Title | Year | Journal | Article |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID504810 | Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID504812 | Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign | 2010 | Endocrinology, Jul, Volume: 151, Issue:7
| A small molecule inverse agonist for the human thyroid-stimulating hormone receptor. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
AID541352 | Effect on secondary structure of alpha-glucosidase assessed as beta-sheet content at 0.3 uM at circular dichroism method | 2010 | Journal of medicinal chemistry, Dec-09, Volume: 53, Issue:23
| Hydroxycoumarin derivatives: novel and potent α-glucosidase inhibitors. |
AID541354 | Effect on secondary structure of alpha-glucosidase assessed as beta-turn content at 0.3 uM at circular dichroism method | 2010 | Journal of medicinal chemistry, Dec-09, Volume: 53, Issue:23
| Hydroxycoumarin derivatives: novel and potent α-glucosidase inhibitors. |
AID541356 | Effect on secondary structure of alpha-glucosidase assessed as random content at 0.3 uM at circular dichroism method | 2010 | Journal of medicinal chemistry, Dec-09, Volume: 53, Issue:23
| Hydroxycoumarin derivatives: novel and potent α-glucosidase inhibitors. |
AID93680 | Inhibitory activity against HIV-1 integrase | 2004 | Bioorganic & medicinal chemistry letters, Mar-22, Volume: 14, Issue:6
| HIV-1 integrase pharmacophore model derived from diverse classes of inhibitors. |
AID541351 | Effect on secondary structure of alpha-glucosidase assessed as beta-sheet content at 0.5 uM at circular dichroism method | 2010 | Journal of medicinal chemistry, Dec-09, Volume: 53, Issue:23
| Hydroxycoumarin derivatives: novel and potent α-glucosidase inhibitors. |
AID541353 | Effect on secondary structure of alpha-glucosidase assessed as beta-turn content at 0.5 uM at circular dichroism method | 2010 | Journal of medicinal chemistry, Dec-09, Volume: 53, Issue:23
| Hydroxycoumarin derivatives: novel and potent α-glucosidase inhibitors. |
AID541263 | Inhibition of beta-glucosidase at 400 uM using salicin substrate | 2010 | Journal of medicinal chemistry, Dec-09, Volume: 53, Issue:23
| Hydroxycoumarin derivatives: novel and potent α-glucosidase inhibitors. |
AID93533 | Inhibitory activity against 3'-processing of DNA by HIV-1 integrase | 1997 | Journal of medicinal chemistry, Jan-17, Volume: 40, Issue:2
| Coumarin-based inhibitors of HIV integrase. |
AID541494 | Inhibition of beta-glucosidase using salicin substrate | 2010 | Journal of medicinal chemistry, Dec-09, Volume: 53, Issue:23
| Hydroxycoumarin derivatives: novel and potent α-glucosidase inhibitors. |
AID541355 | Effect on secondary structure of alpha-glucosidase assessed as random content at 0.5 uM at circular dichroism method | 2010 | Journal of medicinal chemistry, Dec-09, Volume: 53, Issue:23
| Hydroxycoumarin derivatives: novel and potent α-glucosidase inhibitors. |
AID541350 | Effect on secondary structure of alpha-glucosidase assessed as alpha-helix content at 0.3 uM at circular dichroism method | 2010 | Journal of medicinal chemistry, Dec-09, Volume: 53, Issue:23
| Hydroxycoumarin derivatives: novel and potent α-glucosidase inhibitors. |
AID91424 | Integration of DNA by HIV -1 integrase | 1997 | Journal of medicinal chemistry, Jan-17, Volume: 40, Issue:2
| Coumarin-based inhibitors of HIV integrase. |
AID541342 | Inhibition of Aspergillus oryzae Beta-galactosidase at 400 uM | 2010 | Journal of medicinal chemistry, Dec-09, Volume: 53, Issue:23
| Hydroxycoumarin derivatives: novel and potent α-glucosidase inhibitors. |
AID541338 | Inhibition of alpha-glucosidase using para-nitrophenyl substrate | 2010 | Journal of medicinal chemistry, Dec-09, Volume: 53, Issue:23
| Hydroxycoumarin derivatives: novel and potent α-glucosidase inhibitors. |
AID541349 | Effect on secondary structure of alpha-glucosidase assessed as alpha-helix content at 0.5 uM bt circular dichroism method | 2010 | Journal of medicinal chemistry, Dec-09, Volume: 53, Issue:23
| Hydroxycoumarin derivatives: novel and potent α-glucosidase inhibitors. |
AID541341 | Inhibition of Aspergillus oryzae Beta-galactosidase | 2010 | Journal of medicinal chemistry, Dec-09, Volume: 53, Issue:23
| Hydroxycoumarin derivatives: novel and potent α-glucosidase inhibitors. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |